Commit To Buy Portola Pharmaceuticals At $22.50, Earn 18.6% Annualized Using Options

Investors considering a purchase of Portola Pharmaceuticals, Inc. ( PTLA) stock, but cautious about paying the going market price of $26.58/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2015 put at the $22.50 strike, which has a bid at the time of this writing of $2.50. Collecting that bid as the premium represents a 11.1% return against the $22.50 commitment, or a 18.6% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

START SLIDESHOW:
Top YieldBoost Puts of the S&P 500 »

Selling a put does not give an investor access to PTLA's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $22.50 strike if doing so produced a better outcome than selling at the going market price. ( Do options carry counterparty risk? This and six other common options myths debunked). So unless Portola Pharmaceuticals, Inc. sees its shares fall 15.3% and the contract is exercised (resulting in a cost basis of $20.00 per share before broker commissions, subtracting the $2.50 from $22.50), the only upside to the put seller is from collecting that premium for the 18.6% annualized rate of return.

Below is a chart showing the trailing twelve month trading history for Portola Pharmaceuticals, Inc., and highlighting in green where the $22.50 strike is located relative to that history:

Loading+chart++2014+TickerTech.com

The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the March 2015 put at the $22.50 strike for the 18.6% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Portola Pharmaceuticals, Inc. (considering the last 252 trading day closing values as well as today's price of $26.58) to be 55%. For other put options contract ideas at the various different available expirations, visit the PTLA Stock Options page of StockOptionsChannel.com.

If you liked this article you might like

Portola Shares Lower After Update on Anticoagulant Launch -- Biotech Movers

Portola Shares Lower After Update on Anticoagulant Launch -- Biotech Movers

Southwest Airlines, Delta Air Lines, GE: 'Mad Money' Lightning Round

Southwest Airlines, Delta Air Lines, GE: 'Mad Money' Lightning Round

Real Story Behind Tech's Selloff: Cramer's 'Mad Money' Recap (Tuesday 9/26/17)

Real Story Behind Tech's Selloff: Cramer's 'Mad Money' Recap (Tuesday 9/26/17)

Portola Shares Lower After Pricing Stock Offering - Biotech Movers

Portola Shares Lower After Pricing Stock Offering - Biotech Movers

Norwegian Cruise Line, iRobot, Bank of America: 'Mad Money' Lightning Round

Norwegian Cruise Line, iRobot, Bank of America: 'Mad Money' Lightning Round